Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Adenocarcinoma
Scientists at University of Mississippi release new data on adenocarcinoma
June 23rd, 2009
According to recent research from the United States, "Cyathocline purpurea has been traditionally used to treat various diseases including cancers for many years. However, these applications of C. purpurea have not been supported by pharmacological investigation." "The objective of this study is to investigate the anticancer activities of three main constituents such as santamarine, 9 beta-acetoxycostunolide and 9 beta-acetoxyparthenolide isolated from C. purpurea in vitro. Cell viability was determined by trypan blue exclusion and methylene blue assays. Colony formation was assessed by microtitration cloning assay. DNA synthesis was determined by tritiated thymidine...
Source: Cancer Weekly (2009-06-23)
|
